ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J06BA02 | BioHuman | Human normal immunoglobulin - 4g/20ml | 10478 | 63320/1 | CUVITRU | 200mg/ml | 1x20ml | Injectable solution | SC | Abela Frères S.A.L. | Baxalta Belgium Manufacturing SA | Belgium | 29,806,627 L.L | 19.35 | D | Baxalta Innovations GmbH | Austria | 12/12/20 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J06BA02 | BioHuman | Immunoglobulin human - 4g/20ml | 9718 | 172818/1 | HIZENTRA 4G | 20% | 1 x 20ml | Injectable solution | SC | Benta Trading Co s.a.l. | Packed by Benta SAL Lebanon under license from CSL Behring AG, Switzerland | Lebanon | 33,454,642 L.L | 19.35 | D | 12/12/20 | 0 | ||
J06BA02 | BioHuman | Human normal immunoglobulin - 8g/40ml | 10479 | 63420/1 | CUVITRU | 200mg/ml | 1x40ml | Injectable solution | SC | Abela Frères S.A.L. | Baxalta Belgium Manufacturing SA | Belgium | 53,593,818 L.L | 10.71 | E1 | Baxalta Innovations GmbH | Austria | 12/12/20 | 0 |